Pangenomic Health Subsidiary Signs Rental Agreement with Psy Integrated Health, Makes Progress Towards Development of Joint Testing Facility
The rental agreement will cover an initial term of 6 months, ending August 1, 2023. Further to the Company's news release dated January 26, 2023, MUJN Diagnostics and Psyi are continuing to work towards a definitive agreement with respect to their proposed joint venture for the joint development of a brain health targeted biomarker diagnostics service to support clients being treated with ketamine assisted therapy. Additional details are expected to be announced upon the execution of a definitive agreement for the proposed joint venture. No assurances can be made that the parties will successfully negotiate and enter into a definitive agreement, or that the proposed joint venture will proceed in the timeframe currently contemplated or at all.